Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Jul 28, 2021
Date Accepted: Nov 27, 2021

The final, peer-reviewed published version of this preprint can be found here:

Leveraging a Consumer-Based Product to Develop a Cancer-Specific Mobile Meditation App: Prototype Development Study

Huberty J, Bhuiyan N, Neher T, Joeman L, Mesa R, Larkey L

Leveraging a Consumer-Based Product to Develop a Cancer-Specific Mobile Meditation App: Prototype Development Study

JMIR Form Res 2022;6(1):e32458

DOI: 10.2196/32458

PMID: 35029528

PMCID: 8800087

Leveraging a consumer-based product to develop a cancer-specific mobile meditation app: Prototype development study

  • Jennifer Huberty; 
  • Nishat Bhuiyan; 
  • Taylor Neher; 
  • Lynda Joeman; 
  • Ruben Mesa; 
  • Linda Larkey

ABSTRACT

Background:

Mobile meditation apps may offer a long-term, accessible, and effective solution for ongoing symptom management in cancer patients/survivors. However, there are currently no commercial cancer-specific meditation apps that reflect cancer specialist expertise, input from cancer patients/survivors, and features and content specific to cancer patients/survivors’ needs.

Objective:

To gain insight (via surveys, daily journals, and focus groups) from cancer patients/survivors, health care providers, and current Calm subscribers (consumer-based mobile meditation app) who were patients/survivors to develop a prototype of a mobile meditation app specifically designed for cancer patients/survivors.

Methods:

Participants were recruited via prior partnerships, word-of-mouth referrals, and recruitment posts on Facebook and Instagram. Cancer patients/survivors and healthcare providers were instructed to download and use the Calm app for at least 10 min/day for seven days, completed an online daily journal for seven days, and participated in a virtual focus group (one for cancer patients/survivors and one for providers). Current Calm subscribers who were cancer patients/survivors completed an online survey about different aspects of the Calm app and participated in a third virtual focus group. Data was qualitatively analyzed using a combination of deductive and inductive coding.

Results:

A total of 27 participants (11 cancer patients/survivors, 10 healthcare providers, 6 current Calm subscribers) completed the study. Similar themes and sub-themes were found across surveys, daily journals, and focus groups, and fell into two major categories: content and functionality, with cancer-specific and non-cancer specific themes within each. The majority of content preferences and suggestions that arose were cancer-specific, such as content related to negative emotions or feelings (e.g., anxiety, grief, trauma/PTSD, fear of recurrence, isolation, etc.), positive feelings and finding meaning (e.g., gratitude, storytelling, acceptance), scenarios and experiences (e.g., waiting, treatment-specific mediations), type and stage of cancer journey, and movement modifications. Some of the non-cancer specific themes under app content included sleep, music, and visualizations. In terms of app functionality, the majority of participants expressed interest in having a section/tab/area of the app that was specifically geared toward cancer patients/survivors. Preferences and suggestions for cancer-specific functionality features included options based on symptoms or journey, being able to being able to communicate with other patients of survivors to share suggestions for specific meditations, and having an emergency toolkit for patients/survivors.

Conclusions:

Findings from cancer patients/survivors, health care providers, and current Calm subscribers who were patients/survivors (to be incorporated into the development of the prototype) fell into two major categories: 1) content of the app and 2) functionality of the app. The prototype’s form and function will be pilot tested among 30 cancer patients/survivors in a 4-week study, and the resulting feasibility data will be used to inform the final app design and an efficacy study.


 Citation

Please cite as:

Huberty J, Bhuiyan N, Neher T, Joeman L, Mesa R, Larkey L

Leveraging a Consumer-Based Product to Develop a Cancer-Specific Mobile Meditation App: Prototype Development Study

JMIR Form Res 2022;6(1):e32458

DOI: 10.2196/32458

PMID: 35029528

PMCID: 8800087

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.